A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)

Author: Proctor S.J.   Mackie M.   Dawson A.   White J.   Prescott R.J.   Lucraft H.L.   Angus B.   Jackson G.H.   Lennard A.L.   Hepplestone A.   Taylor P.R.A.  

Publisher: Elsevier

ISSN: 0959-8049

Source: European Journal of Cancer, Vol.38, Iss.6, 2002-01, pp. : 795-806

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content